Normalization of Serum Lipase Levels Versus Resolution of Abdominal Pain: A Comparison of Preoperative Management in Children With Biliary Pancreatitis

J Surg Res. 2020 Aug:252:133-138. doi: 10.1016/j.jss.2020.03.012. Epub 2020 Apr 9.

Abstract

Background: Controversy exists over the timing of cholecystectomy for biliary pancreatitis in children. Some surgeons await normalization of serum lipase levels while others are guided by resolution of abdominal pain; however, there are minimal data to support either practice. We hypothesized that resolution of abdominal pain is equivalent in outcome to awaiting normalization of lipase levels in patients undergoing cholecystectomy for biliary pancreatitis.

Methods: After institutional review board (IRB) approval, the medical record was retrospectively queried for all cases of cholecystectomy for biliary pancreatitis at our institution from 2007 to 2017. Patients undergoing chemotherapy, admitted for another cause, or who had severe underlying comorbidities like ventilator dependence were excluded. Patients were stratified into two cohorts: those managed preoperatively by normalization of serum lipase levels versus resolution of abdominal pain. Demographics, serum lipase levels, postoperative complications, cost of stay, readmissions, and return to the emergency department were collected and analyzed using multivariate regression.

Results: Seventy-four patients met inclusion: 29 patients had lipase levels trended until normalization compared with 45 patients who had resolution of abdominal pain prior to cholecystectomy. Among the two cohorts there was no statistical difference in age, gender, race, ethnicity, or type of preoperative imaging used. Trended patients were found to have more serum lipase levels tested (8.5 ± 6.2 versus 3.4 ± 2.5, P < 0.0001). The trended lipase cohort was significantly more likely to require preoperative total parenteral nutrition (48% versus 11%, P = 0.007) and consequently a longer time before resuming a diet (10 ± 7.3 versus 4.6 ± 2.4 d, P < 0.0001). When comparing the two groups, we found no significant difference in the duration of surgery, postoperative complications, or readmissions. Lipase trended patients had a significantly longer length of stay compared with nontrended patients (11.5 ± 8.1 versus 4.2 ± 2.3 d, P < 0.0001) and had a higher total cost of stay ($38,094 ± 25,910 versus $20,205 ± 5918, P = 0.0007).

Conclusions: Our data suggest that in children with biliary pancreatitis, proceeding with cholecystectomy after resolution of abdominal pain is equivalent in outcomes to trending serum lipase levels but is more cost-effective with a decreased length of stay and decreased need for preoperative total parenteral nutrition.

Keywords: Biliary pancreatitis; Gallstones; Lipase trend; Pediatric cholecystectomy.

Publication types

  • Comparative Study

MeSH terms

  • Abdominal Pain / diagnosis*
  • Abdominal Pain / economics
  • Abdominal Pain / etiology
  • Abdominal Pain / therapy
  • Adolescent
  • Child
  • Cholecystectomy, Laparoscopic / adverse effects
  • Cholecystectomy, Laparoscopic / economics
  • Cholecystectomy, Laparoscopic / standards*
  • Cholecystectomy, Laparoscopic / statistics & numerical data
  • Clinical Decision-Making / methods
  • Cost-Benefit Analysis / statistics & numerical data
  • Female
  • Gallstones / blood
  • Gallstones / complications*
  • Gallstones / economics
  • Gallstones / therapy
  • Humans
  • Length of Stay / economics
  • Length of Stay / statistics & numerical data
  • Lipase / blood*
  • Male
  • Operative Time
  • Pain Measurement
  • Pancreatitis / blood
  • Pancreatitis / economics
  • Pancreatitis / etiology
  • Pancreatitis / surgery*
  • Parenteral Nutrition, Total / statistics & numerical data
  • Patient Readmission / statistics & numerical data
  • Postoperative Complications / economics
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Practice Guidelines as Topic
  • Preoperative Care / economics
  • Preoperative Care / statistics & numerical data
  • Retrospective Studies
  • Time Factors
  • Time-to-Treatment / economics
  • Time-to-Treatment / standards*
  • Time-to-Treatment / statistics & numerical data
  • Treatment Outcome

Substances

  • Lipase